Lymphocyte

A novel approach to tumor-infiltrating lymphocyte therapy yielded higher response rates among patients with metastatic gastrointestinal cancers than prior strategies, according to results of a phase 2 trial.

CHICAGO — A biomarker of systemic inflammation, the neutrophil-to-lymphocyte ratio during the first trimester of pregnancy may predict the development of preeclampsia, data showed.

Interleukin-6 and neutrophil-to-lymphocyte ratio may be used as preoperative risk stratifying tools among patients undergoing total knee arthroplasty for osteoarthritis, according to results presented at the Virtual EFORT Congress.

Biopharma company Kite, a subsidiary of Gilead, has submitted a biologics license application to the FDA for the company’s investigational chimeric antigen receptor T-cell therapy KTE-X19 for the treatment of adults with relapsed or refectory mantle cell lymphoma.